SCHEDULE 13G: Streeterville Capital Discloses 6.7% Passive Stake in Jaguar Health

Streeterville Capital LLC, along with Streeterville Management LLC and John M. Fife, has reported a passive beneficial ownership of 6.7% in Jaguar Health, Inc., totaling 45,478 shares of common stock.

Summary

• Streeterville Capital LLC, Streeterville Management LLC, and John M. Fife have filed a Schedule 13G, indicating beneficial ownership in Jaguar Health, Inc.
• The reporting persons collectively beneficially own 45,478 shares of Jaguar Health, Inc. Common Stock.
• This ownership represents 6.7% of the company's outstanding common stock, based on 674,043 shares outstanding as of March 31, 2025, as disclosed in the Issuer's 10-K.
• The filing states that the securities were acquired and are held for passive investment purposes, without the intent to change or influence control of the issuer.

Sentiment

Score: 5

Explanation: The document is a factual disclosure of a passive ownership stake and does not contain information that would significantly alter the perceived sentiment of the company's performance or prospects, beyond the neutral implication of a new significant investor.

Positives

• A new significant institutional investor, Streeterville Capital LLC, has disclosed a 6.7% stake, which could be viewed as a vote of confidence in Jaguar Health, Inc.
• The filing indicates a passive investment intent, suggesting the investor is not seeking to influence or change control of the company.

Negatives

• The document itself does not contain any explicit negative information regarding Jaguar Health, Inc.

Risks

• The filing explicitly states that the securities were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer, mitigating the risk of an activist investor seeking control.

Future Outlook

NA

Industry Context

This Schedule 13G filing is a standard regulatory disclosure of a significant passive ownership stake by an institutional investor in a publicly traded company. It does not provide information related to broader industry trends or competitive landscape.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: The disclosure of a new significant passive investor holding 6.7% of the common stock may provide some level of confidence or signal institutional interest in the company.

Next Steps

• NA

Key Dates

Keywords

Jaguar Health Inc., Streeterville Capital LLC, Streeterville Management LLC, John M. Fife, Schedule 13G, Beneficial Ownership, Common Stock, Passive Investment, SEC Filing, Institutional Investor